Loading data
DMRANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 26.88 m USD | 6.4 m USD | 23.77 m USD | 48.21 m USD | 38.49 m USD |
| Operating profit | -210.87 m USD | -22.26 m USD | -39.91 m USD | -61.21 m USD | -52.23 m USD |
| Profit before tax | -209.79 m USD | -21.4 m USD | -38.35 m USD | -61.62 m USD | -51.75 m USD |
| Income tax expense | 50 k USD | 41 k USD | — | — | — |
| Net income (reported basis) | -209.84 m USD | -21.44 m USD | -38.35 m USD | -61.62 m USD | -51.75 m USD |
| Basic earnings per share | 3.98 USD/share | -18.53 USD/share | -36.08 USD/share | -2.43 USD/share | -2.05 USD/share |
| Diluted earnings per share | 3.98 USD/share | -18.53 USD/share | -36.08 USD/share | -2.43 USD/share | -2.05 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.